Specifically, upregulation of the Fas/FasL death pathway has been exhibited in breast cancer, where upregulation of FasL expression was seen with an increased apoptosis level of tumor infiltrating lymphocytes (Cheng, 2006). The gene discussed is FAS; the disease is neoplasm.